Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study-Reference-Cited by-同舟云学术

Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study

Published:2023-06-06 Issue:5 Volume:24 Page:799-808
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Huang Hao-Hsin,Shen Dereck,Chan Tom C.,Cho Yung-Tsu,Tang Chao-Hsiun,Chu Chia-Yu^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40257-023-00787-3.pdf

Reference27 articles.

1. Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009;122(2):121–5.

2. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–43.

3. Beasley R. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet (London, England). 1998;351(9111):1225–32.

4. Cho YT, Hsieh WT, Chan TC, Tang CH, Chu CY. Prevalence of baseline comorbidities in patients with atopic dermatitis: a population-based cohort study in Taiwan. JAAD Int. 2020;1(1):50–8.

5. Cai SC, Li W, Tian EA, Allen JC, Tey HL. Topical calcineurin inhibitors in eczema and cancer association: a cohort study. J Dermatolog Treat. 2016;27(6):531–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments;Frontiers in Immunology;2023-10-05